Verrica Pharmaceuticals Inc (VRCA)
1.44
-0.09
(-5.88%)
USD |
NASDAQ |
Nov 04, 16:00
1.05
-0.39
(-27.08%)
After-Hours: 20:00
Verrica Pharmaceuticals Total Assets (Quarterly): 52.01M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 52.01M |
March 31, 2024 | 66.31M |
December 31, 2023 | 81.60M |
September 30, 2023 | 97.15M |
June 30, 2023 | 62.20M |
March 31, 2023 | 68.64M |
December 31, 2022 | 44.72M |
September 30, 2022 | 49.15M |
June 30, 2022 | 63.44M |
March 31, 2022 | 71.62M |
December 31, 2021 | 80.12M |
September 30, 2021 | 88.76M |
June 30, 2021 | 99.03M |
March 31, 2021 | 108.10M |
Date | Value |
---|---|
December 31, 2020 | 74.15M |
September 30, 2020 | 79.94M |
June 30, 2020 | 87.24M |
March 31, 2020 | 94.44M |
December 31, 2019 | 68.42M |
September 30, 2019 | 76.07M |
June 30, 2019 | 81.25M |
March 31, 2019 | 85.98M |
December 31, 2018 | 91.91M |
September 30, 2018 | 98.80M |
June 30, 2018 | 104.72M |
March 31, 2018 | 29.40M |
December 31, 2017 | 9.083M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
44.72M
Minimum
Dec 2022
108.10M
Maximum
Mar 2021
75.63M
Average
74.15M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 6.851B |
Elite Pharmaceuticals Inc | 87.85M |
Eagle Pharmaceuticals Inc | 404.82M |
TELA Bio Inc | 60.20M |
Terns Pharmaceuticals Inc | 230.88M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 65.31M |
Shareholders Equity (Quarterly) | -13.30M |
Debt to Equity Ratio | -3.214 |
Current Ratio | 2.360 |
Net Debt Paydown Yield | -2.76% |